» Articles » PMID: 28379782

Overcoming Barriers and Identifying Opportunities for Developing Maternal Immunizations: Recommendations From the National Vaccine Advisory Committee

Overview
Publisher Sage Publications
Specialty Public Health
Date 2017 Apr 6
PMID 28379782
Citations 12
Affiliations
Soon will be listed here.
Citing Articles

Factors associated with pregnant women's willingness to receive maternal pertussis vaccination in Guizhou Province, China: An exploratory cross-sectional study.

Jiang F, Ye X, Wang Y, Tang N, Feng J, Gao Y Hum Vaccin Immunother. 2024; 20(1):2331870.

PMID: 38575528 PMC: 10996833. DOI: 10.1080/21645515.2024.2331870.


Vaccine package inserts and prescribing habits of obstetricians-gynecologists for maternal vaccination.

Saini J, Ellingson M, Beigi R, MacDonald N, Top K, Carroll S Hum Vaccin Immunother. 2021; 17(10):3761-3770.

PMID: 34236947 PMC: 8437486. DOI: 10.1080/21645515.2021.1942714.


Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement.

Abu-Raya B, Maertens K, Edwards K, Omer S, Englund J, Flanagan K Front Immunol. 2020; 11:1282.

PMID: 32670282 PMC: 7326941. DOI: 10.3389/fimmu.2020.01282.


Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.

Zhou S, Greene C, Song Y, Zhang R, Rodewald L, Feng L Hum Vaccin Immunother. 2019; 16(3):602-611.

PMID: 31589548 PMC: 7227693. DOI: 10.1080/21645515.2019.1664230.


Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza.

Thompson M, Li D, Naleway A, Ferber J, Henninger M, Shifflett P BMC Pregnancy Childbirth. 2019; 19(1):161.

PMID: 31068160 PMC: 6507168. DOI: 10.1186/s12884-019-2280-0.


References
1.
. Influenza vaccination coverage among pregnant women: 2011-12 influenza season, United States. MMWR Morb Mortal Wkly Rep. 2012; 61:758-63. View

2.
Elahi M, Eshera N, Bambata N, Barr H, Lyn-Cook B, Beitz J . The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update. J Womens Health (Larchmt). 2016; 25(3):222-34. PMC: 4790210. DOI: 10.1089/jwh.2015.5671. View

3.
Roberts J, Gruber M . Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy. Vaccine. 2015; 33(8):966-72. DOI: 10.1016/j.vaccine.2014.12.068. View

4.
Steinhoff M . Assessments of vaccines for prenatal immunization. Vaccine. 2013; 31 Suppl 4:D27-30. DOI: 10.1016/j.vaccine.2013.02.031. View

5.
Da Silva F, Gonik B, McMillan M, Keech C, Dellicour S, Bhange S . Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2016; 34(49):6057-6068. PMC: 5139804. DOI: 10.1016/j.vaccine.2016.03.044. View